Curis (CRIS) Interest Expenses (2013 - 2025)
Curis (CRIS) reported Interest Expenses of $314000.0 for Q4 2025, down 63.1% on a YoY basis from $851000.0 in Q4 2024, and down 64.52% quarter-over-quarter from $885000.0 in Q3 2025.
Curis (CRIS) Interest Expenses (2013 - 2025) Analysis & Trends
Curis has reported Interest Expenses for 13 years, with the latest figure at $314000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 63.1% year-over-year to $314000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 31.16% YoY), and the FY2025 full-year result was $2.2 million, up 255.28% from the prior year.
- Interest Expenses for Q4 2025 stood at $314000.0, down from $885000.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.7 million in Q4 2022, with the low at -$150000.0 in Q3 2024.
- Historically, Interest Expenses has averaged $703100.0 across 5 years, with a median of $744500.0 in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses slumped 124.23% — and 2025, when it soared 5525.0%.
- Curis' Interest Expenses stood at $1.1 million in 2021, then jumped by 49.28% to $1.7 million in 2022, then plunged by 89.22% to $178000.0 in 2023, then soared by 378.09% to $851000.0 in 2024, then slumped by 63.1% to $314000.0 in 2025.
- The last three Interest Expenses figures came in at $314000.0 (Q4 2025), $885000.0 (Q3 2025), and $434000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 314,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 434,000.00 |
| Jun 30, 2025 | 434,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | 851,000.00 |
| Dec 31, 2024 | 851,000.00 |
| Sep 30, 2024 | -150,000.00 |
| Sep 30, 2024 | -150,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -78,000.00 |
| Mar 31, 2024 | -78,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Sep 30, 2023 | 619,000.00 |
| Sep 30, 2023 | 619,000.00 |